亚宝药业

- 600351

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
亚宝药业(600351) 利润表
单位:万元
报表日期2026-06-302026-03-312025-12-312025-09-302025-06-30
一、营业总收入114,494.6557,202.23224,006.35170,871.22113,940.85
营业收入114,494.6557,202.23224,006.35170,871.22113,940.85
二、营业总成本91,615.5944,634.04191,000.03142,210.5694,432.17
营业成本52,684.4826,745.34106,378.8781,787.9354,058.58
营业税金及附加1,724.94820.483,426.102,659.991,729.09
销售费用21,714.6910,357.6345,180.1232,746.3022,214.52
管理费用11,226.954,911.8024,605.4718,038.5411,673.29
财务费用-77.04-36.04-317.59-251.34-97.01
研发费用4,341.571,834.8411,727.067,229.154,853.70
资产减值损失----------
公允价值变动收益-1,630.81-1,406.111,900.43108.5541.97
投资收益234.9490.407,403.87155.7299.28
其中:对联营企业和合营企业的投资收益86.07-10.10910.71-30.58-20.39
汇兑收益----------
三、营业利润23,126.8412,437.5637,083.8825,325.8921,201.78
加:营业外收入146.3943.30712.03328.94114.15
减:营业外支出341.885.60350.14318.4372.91
其中:非流动资产处置损失----------
四、利润总额22,931.3612,475.2637,445.7725,336.4021,243.01
减:所得税费用5,008.241,777.967,455.845,487.253,724.17
五、净利润17,923.1210,697.3029,989.9319,849.1517,518.84
归属于母公司所有者的净利润17,759.6510,666.2332,001.3421,509.4317,439.72
少数股东损益163.4731.07-2,011.41-1,660.2879.12
六、每股收益
基本每股收益(元/股)0.25660.15410.45760.30660.2483
稀释每股收益(元/股)----------
七、其他综合收益136.38---316.18----
八、综合收益总额18,059.5010,697.3029,673.7519,849.1517,518.84
归属于母公司所有者的综合收益总额17,896.0310,666.2331,685.1621,509.4317,439.72
归属于少数股东的综合收益总额163.4731.07-2,011.41-1,660.2879.12
下载全部历史数据到excel中 返回页顶